About Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku
During the past decade, Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
2005-03-01
2009-12-01
Completed
260
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
2007-07-01
2014-10-01
Completed
60
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
2014-08-01
2021-07-01
Completed
68
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
2001-03-01
2027-12-01
Recruiting
120,000
Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
2016-12-20
2017-04-17
Completed
530
A Tube Feeding Study in Malnourished Population With Diabetes
2018-11-29
2020-07-01
Completed
49
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku"
#1 collaborator was "KCRI" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku
According to Clinical.Site data, the most researched conditions in "Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku" are
"B-cell Non-Hodgkin Lymphoma" (1 trials) and "CD20-positive Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku" in a lesser frequency.
Clinical Trials Intervention Types at Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku
Most popular intervention types in "Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Mosunetuzumab" (1 trials), "Obinutuzumab" (1 trials) and "Polatuzumab Vedotin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku
The vast majority of trials in "Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku" are
2 trials for "All" genders.
Clinical Trials Status at Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku
Currently, there are NaN active trials in "Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku".
1 are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".